Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer

Oncology Reports

Volumn 33, Issue 1, 2015, Pages 485-493

  Tsai, Kuo Wang ^a   Hu, Ling Yueh ^b   Chen, Ting Wen ^c   Li, Sung Chou ^d   Ho, Meng Ru ^e   Yu, Shou Yu ^a   Tu, Ya Ting ^a   Chen, Wei Shone ^f   Lam, Hing Chung ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e BIODIVERSITY RESEARCH CENTER   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Endothelin 1; Gastric cancer; MicroRNA; MiR 1

Indexed keywords

ENDOTHELIN 1; LET 7C; MICRORNA; MICRORNA 1; MICRORNA 101; MICRORNA 125A; MICRORNA 144; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN1 MICRORNA, HUMAN;

ARTICLE; CANCER CELL; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DATA BASE; DNA METHYLATION; DRUG TARGETING; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS; THE CANCER GENOME ATLAS; 3' UNTRANSLATED REGION; CPG ISLAND; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; STOMACH TUMOR; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; ENDOTHELIN-1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RNA INTERFERENCE; STOMACH NEOPLASMS;

EID: 84916221840     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3598     Document Type: Article

References (50)

1. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
2. Kedzierski RM and Yanagisawa M: Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41: 851-876, 2001.
3. Rubanyi GM and Polokoff MA: Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325-415, 1994.
4. Grimshaw MJ: Endothelins in breast tumour cell invasion. Cancer Lett 222: 129-138, 2005.
5. Asham E, Shankar A, Loizidou M, et al: Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ETA receptor antagonism. Br J Cancer 85: 1759-1763, 2001.
6. Eberle J, Fecker LF, Orfanos CE and Geilen CC: Endothelin-1 decreases basic apoptotic rates in human melanoma cell lines. J Invest Dermatol 119: 549-555, 2002.
7. Douglas ML, Richardson MM and Nicol DL: Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma. Cancer 100: 2118-2124, 2004.
8. Kim TH, Xiong H, Zhang Z and Ren B: β-Catenin activates the growth factor endothelin-1 in colon cancer cells. Oncogene 24: 597-604, 2005.
9. Abdel-Gawad IA, Hassanein HM, Bahgat NA, et al: Study of endothelin-1 and vascular endothelial growth factor in patients with cancer colon. J Egypt Natl Canc Inst 20: 216-223, 2008.
10. Said N, Smith S, Sanchez-Carbayo M and Theodorescu D: Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. J Clin Invest 121: 132-147, 2011.
11. Nelson JB, Udan MS, Guruli G and Pflug BR: Endothelin-1 inhibits apoptosis in prostate cancer. Neoplasia 7: 631-637, 2005.
12. Rosano L, Spinella F and Bagnato A: Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 13: 637-651, 2013.
13. Nelson JB, Lee WH, Nguyen SH, et al: Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 57: 35-37, 1997.
14. Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA and Jones PA: The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 10: 903-910, 2001.
15. Cohen AJ, Belinsky S, Franklin W and Beard S: Molecular and physiologic evidence for 5'CpG island methylation of the endothelin B receptor gene in lung cancer. Chest 121: 27S-28S, 2002.
16. Lo KW, Tsang YS, Kwong J, To KF, Teo PM and Huang DP: Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer 98: 651-655, 2002.
17. Zhao BJ, Sun DG, Zhang M, Tan SN and Ma X: Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Dis Esophagus 22: 55-61, 2009.
18. Mathieu MN and Chevillard C: Endothelin-1 and ETA receptor subtype are expressed in the gastric HGT-1 cell line. J Cardiovasc Pharmacol 26 (Suppl 3): S508-S509, 1995.
19. Ferrari-Bravo A, Franciosi C, Lissoni P, Fumagalli L and Uggeri F: Effects of oncological surgery on endothelin-1 secretion in patients with operable gastric cancer. Int J Biol Markers 15: 56-57, 2000.
20. Stow LR, Jacobs ME, Wingo CS and Cain BD: Endothelin-1 gene regulation. FASEB J 25: 16-28, 2011.
21. Pan HW, Li SC and Tsai KW: MicroRNA dysregulation in gastric cancer. Curr Pharm Des 19: 1273-1284, 2013.
22. Wu HH, Lin WC and Tsai KW: Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med 16: e1, 2014.
23. Jacobs ME, Wingo CS and Cain BD: An emerging role for microRNA in the regulation of endothelin-1. Front Physiol 4: 22, 2013.
24. Yeligar S, Tsukamoto H and Kalra VK: Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1α and microRNA-199. J Immunol 183: 5232-5243, 2009.
25. Li D, Yang P, Xiong Q, et al: MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J Hypertens 28: 1646-1654, 2010.
26. Li D, Yang P, Li H, et al: MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. Life Sci 91: 440-447, 2012.
27. Li D, He B, Zhang H, et al: The inhibitory effect of miRNA-1 on ET-1 gene expression. FEBS Lett 586: 1014-1021, 2012.
28. Feng B, Cao Y, Chen S, Ruiz M and Chakrabarti S: miRNA-1 regulates endothelin-1 in diabetes. Life Sci 98: 18-23, 2014.
29. Chen WS, Leung CM, Pan HW, et al: Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Oncol Rep 28: 1069-1076, 2012.
30. Teng XJ, Shen ZX, Xiang JJ, et al: Pre-and post-operative plasma big endothelin-1 levels in patients with gastric carcinoma undergoing radical gastrectomy. Anticancer Res 26: 2503-2507, 2006.
31. Whyteside AR, Hinsley EE, Lambert LA, McDermott PJ and Turner AJ: ECE-1 influences prostate cancer cell invasion via ET-1-mediated FAK phosphorylation and ET-1-independent mechanisms. Can J Physiol Pharmacol 88: 850-854, 2010.
32. Smollich M, Götte M, Yip GW, et al: On the role of endothelinconverting enzyme-1 (ECE-1) and neprilysin in human breast cancer. Breast Cancer Res Treat 106: 361-369, 2007.
33. Dawson LA, Maitland NJ, Berry P, Turner AJ and Usmani BA: Expression and localization of endothelin-converting enzyme-1 in human prostate cancer. Exp Biol Med 231: 1106-1110, 2006.
34. Awano S, Dawson LA, Hunter AR, Turner AJ and Usmani BA: Endothelin system in oral squamous carcinoma cells: specific siRNA targeting of ECE-1 blocks cell proliferation. Int J Cancer 118: 1645-1652, 2006.
35. Van Beneden R, Michel L, Havaux X, Delos M and Donckier J: Increased expression of endothelin-1 converting enzyme in human thyroid carcinoma. Clin Endocrinol 60: 146-147, 2004.
36. Wiesmann F, Veeck J, Galm O, et al: Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer. Breast Cancer Res 11: R34, 2009.
37. Wang R, Lohr CV, Fischer K, et al: Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer. Int J Cancer 132: 1004-1012, 2013.
38. Lim JY, Yoon SO, Seol SY, et al: Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. World J Gastroenterol 19: 7078-7088, 2013.
39. Ma J, Liu J, Wang Z, et al: NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1β induction. Mol Cancer 13: 40, 2014.
40. Peng WZ, Ma R, Wang F, Yu J and Liu ZB: Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci 15: 4031-4048, 2014.
41. Yoshino H, Chiyomaru T, Enokida H, et al: The tumoursuppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818, 2011.
42. Wu CD, Kuo YS, Wu HC and Lin CT: MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells. J Biomed Sci 18: 80, 2011.
43. Wang F, Song G, Liu M, Li X and Tang H: miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett 585: 3263-3269, 2011.
44. Nohata N, Sone Y, Hanazawa T, et al: miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2: 29-42, 2011.
45. Nasser MW, Datta J, Nuovo G, et al: Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 283: 33394-33405, 2008.
46. Kinoshita T, Nohata N, Fuse M, et al: Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun 418: 378-383, 2012.
47. Hudson RS, Yi M, Esposito D, et al: MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res 40: 3689-3703, 2012.
48. Datta J, Kutay H, Nasser MW, et al: Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68: 5049-5058, 2008.
49. Migliore C, Martin V, Leoni VP, et al: MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res 18: 737-747, 2012.
50. Suzuki H, Takatsuka S, Akashi H, et al: Genome-wide profiling of chromatin signatures reveals epigenetic regulation of microRNA genes in colorectal cancer. Cancer Res 71: 5646-5658, 2011.